HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

Pgj2

HCID 5280884
NotesReactions
Basic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
60203-57-8
Standard SMILES
CCCCC[C@H](O)/C=C/[C@H]1C(=O)C=C[C@@H]1C/C=C\CCCC(=O)O
InChIKey
UQOQENZZLBSFKO-POPPZSFYSA-N
Molecular formula
C20H30O4
Average molar mass
334.4 g/mol
Monoisotopic mass
334.21440943

Names & identifiers

Preferred name
Pgj2
IUPAC
(Z)-7-[(1S,5R)-5-[(E,3S)-3-hydroxyoct-1-enyl]-4-oxocyclopent-2-en-1-yl]hept-5-enoic acid
English name
PROSTAGLANDIN J2
Molecular formula
C20H30O4
Molecular weight
334.45

Names & synonyms

prostaglandin J2PGJ29-Deoxy-delta-9-prostaglandin D260203-57-89-Deoxy-delta-9-pgd2DTXSID4041105CHEBI:2748511-oxo-15S-hydroxy-5Z,9,13E-prostatrienoic acidProsta-5,9,13-trien-1-oic acid, 15-hydroxy-11-oxo-, (5Z,13E,15S)-(Z)-7-((1S,5R)-5-((E,3S)-3-hydroxyoct-1-enyl)-4-oxo-1-cyclopent-2-enyl)hept-5-enoic acid(Z)-7-[(1S,5R)-5-[(E,3S)-3-hydroxyoct-1-enyl]-4-oxo-1-cyclopent-2-enyl]hept-5-enoic acidRefChem:928953
Show more names
Aids058772Aids-058772Prostaglandin J2 (PGJ2)Prostaglandin J2 (Standard)Prostaglandin J2, PGD2 analog9-deoxy-delta-9-prostaglandind2Prostaglandin J2 Lipid Maps MS Standard
DTXCID2021105PGJ2 (Prostaglandin J2)(Z)-7-[(1S,5R)-5-[(E,3S)-3-hydroxyoct-1-enyl]-4-oxocyclopent-2-en-1-yl]hept-5-enoic acidCHEMBL1397260(5Z,13E,15S)-15-hydroxy-11-oxoprosta-5,9,13-trien-1-oic acidProstaglandin J2 Lipid Maps(R) MS StandardSR-050000023308-epi-15-J2t-IsoP

Database identifiers

Properties

Computed structural properties

XLogP
3.6
Topological polar surface area
74.6 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
4
Rotatable bonds
12
Heavy atoms
24
Formal charge
0
Complexity
476

Experimental & physicochemical properties

Physical DescriptionSolid
Collision Cross Section188.7 Ų [M-H]- [CCS Type: DT; Buffer gas: N2; Ionization: ESI-; Calculation: Single Field; Dataset: Oxylipins]

Physicochemical properties

Boiling point
521.7 · 521.7±50.0 °C(Predicted)
Density
1.103 · 1.103±0.06 g/cm3(Predicted)
storage temp.
20 °C · −20°C
solubility
100 mg/ml · DMF: >100 mg/ml (from PGD2); DMSO: >50 mg/ml (from PGD2); Ethanol: >75 mg/ml (from PGD2); PBS pH 7.2: >2.7 mg/ml (from 15-deoxy-.DEL
pka
4.75 · 4.75±0.10(Predicted)
form
Liquid
color
Colorless to light yellow
EWG's Food Scores
1 · 1
Symbol(GHS)
2 · GHS02,GHS07
Signal word
Danger

Safety & regulation

Safety data

risk_code
20/21/22-36/37/38-67-66-36-11
Signal word
Danger
Symbol(GHS)
GHS02,GHS07
hazard_code
Xn,Xi,F
safety_code
26-36-33-29-16
Hazard statements
H225-H319-H336
Precautionary statements
P210-P240-P241-P242-P243-P261-P264-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P312-P337+P313-P370+P378-P403+P233-P403+P235-P405-P501

Chemistry & industry

Pharmacology

MeSH Pharmacological ClassificationSubstances that inhibit or prevent the proliferation of NEOPLASMS.
Tissue LocationsNeuron;Platelet
Cellular LocationsExtracellular;Membrane
Metabolite Pathways · 1 item

Acetaminophen Action Pathway;Acetylsalicylic Acid Action Pathway;Antipyrine Action Pathway;Antrafenine Action Pathway;Arachidonic Acid Metabolism;Bromfenac Action Pathway;Carprofen Action Pathway;Celecoxib Action Pathway;Diclofenac Action Pathway;Diflunisal Action Pathway;Total 41 pathways, visit the HMDB page for details

Applications · 2 items

DescriptionProstaglandin J2 (PGJ2) is formed from PGD2 by the elimination of the C-9 hydroxyl group, a process which is accelerated by the presence of albumin. PGJ2 inhibits platelet aggregation with an IC50 of about 5-10 nM. PGJ2 has antimitotic and antiproliferative effects on a variety of cultured normal cells and tumor cell lines. However, this activity has been attributed to further metabolites of PGJ2 and not the parent compound itself.

UsesPGJ2 (Prostaglandin J2) is a Prostaglandin D2 metabolite that has shown potent anti-neoplastic and antiviral activity.

Suppliers17 total

上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
Career Henan Chemica Co+86-0371-86658258 +86-13203830695 · [email protected]
上海优宁维生物科技股份有限公司15921930842 15921930842 · [email protected]

Related reactions

1 records
New reaction record
HRID 1075617 reaction equation
HRID 1075617As reactantuspto-grants-1999_05

Compound notes

Loading…

On this pageBasic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
CAS
60203-57-8
PubChem CID
5280884
DTXSID
DTXSID4041105
ChEMBL
CHEMBL1397260
ChEBI
CHEBI:27485
Nikkaji
J39.531E
Hazard statements
225 · H225-H319-H336
Precautionary statements
210 · P210-P240-P241-P242-P243-P261-P264-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P312-P337+P313-P370+P378-P403+P233-P403+P235-P405-P501
Hazard Codes
Xn,Xi,F
Risk Statements
20 · 20/21/22-36/37/38-67-66-36-11
Safety Statements
26 · 26-36-33-29-16
杭州摩库生物医药科技有限公司
+86-057181025280; +8617767106207 · [email protected]
安耐吉化学&3A(安徽泽升科技有限公司)021-58432009 400-005-6266 · [email protected]
TargetMol 中国(陶术生物)400-821-0310 15002144251 · [email protected]
上海源叶生物科技有限公司13636370518 · [email protected]
成都标样生物科技有限公司028-81700200 13308200041 · [email protected]
BOC Sciences[email protected]
江苏艾康生物医药研发有限公司025-58851090 13913916777 · [email protected]
Aladdin Scientific[email protected]
TargetMol中国(陶术生物)4008200310 15002144251 · [email protected]
上海迈瑞尔生化科技有限公司18621169109 · [email protected]
湖北艾普蒂生物工程有限公司17762444226 · [email protected]
ChemeGen 中国18818260767 · [email protected]
上海一飞生物科技有限公司021-65675885 18964387627 · [email protected]
武汉艾美捷科技有限公司4006800868;027-59626688 18771149750

Additional notes

DefinitionChEBI: A member of the class of prostaglandins J that consists of prosta-5,9,13-trien-1-oic acid substituted by an oxo group at position 11 and a hydroxy group at position 15 (the 5Z,13E,15S stereoisomer).